Company Search:
Advanced Search
Sponsored Links
Pure Biologics SA Company Snapshot
Pure Biologics SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pure Biologics SA with three other pharmaceutical manufacturers in Europe: Erytech Pharma SA of FRANCE (2019 sales of 5.28 million Euros [US$6.16 million] of which 100% was Pharmacy), ExpreS2ion Biotech Holding AB of SWEDEN (13.83 million Swedish Kronor [US$1.53 million] ), and Medincell SA which is based in FRANCE (1.44 million Euros [US$1.68 million] of which 100% was the conduct of research and development ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pure Biologics SA
  Stock Performance Chart for Pure Biologics SA
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 98.00
(Figures in Polish New Zlotys)
1 Week 1.0%   13 Weeks -13.3%  
4 Weeks 11.4%   52 Weeks 184.1%  
Pure Biologics SA Key Data:
  Ticker: PUR Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 16,752,766
(Year Ending Jan 2020).
Employees: N/A
  Currency: Polish New Zlotys Market Cap: 162,092,000
  Fiscal Yr Ends: December Shares Outstanding: 1,654,000
  Share Type: Akcje Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.